Mejares, Rhea Mae .

HRN: 22-41-41  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/14/2026
CEFUROXIME 750MG (VIAL)
02/14/2026
02/20/2026
IV
375mg
Q8H
UTI; T/C Dengue Shock Syndrome
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: